Activation-Induced Cytidine Deaminase in Antibody Diversification and Chromosome Translocation

Advances in Cancer Research

Volumn 113, Issue , 2012, Pages 167-190

  Gazumyan, Anna ^a,b   Bothmer, Anne ^a   Klein, Isaac A ^a   Nussenzweig, Michel C ^a,b   McBride, Kevin M ^c  

^a Laboratory of Molecular Immunology   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; DNA HYBRID; IMMUNOGLOBULIN; INTERLEUKIN 4; MESSENGER RNA; PROTEIN P53; RNA POLYMERASE II; SMALL INTERFERING RNA; SPT5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E47; TRANSCRIPTION FACTOR PAX5; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIBODY STRUCTURE; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLASS SWITCH RECOMBINATION; DNA DAMAGE; DNA RNA HYBRIDIZATION; DNA STRAND BREAKAGE; DNA TEMPLATE; EXOSOME; GENE EXPRESSION REGULATION; GENE LOCUS; GENE TARGETING; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; HALF LIFE TIME; HAPLOINSUFFICIENCY; HUMAN; IMMUNOGENETICS; LYMPHOMAGENESIS; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION; TRANSGENE;

EID: 84858411773     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394280-7.00005-1     Document Type: Chapter

References (121)

1. Abbas A.K., Lichtman A.H., Pillai S. Cellular and Molecular Immunology 2010, Saunders Elsevier, Philadelphia, PA. 6th edn.
2. Adelman K., Marr M.T., Werner J., Saunders A., Ni Z., Andrulis E.D., Lis J.T. Efficient release from promoter-proximal stall sites requires transcript cleavage factor TFIIS. Mol. Cell 2005, 17:103-112.
3. Andrulis E.D., Werner J., Nazarian A., Erdjument-Bromage H., Tempst P., Lis J.T. The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila. Nature 2002, 420:837-841.
4. Aoufouchi S., Faili A., Zober C., D'Orlando O., Weller S., Weill J.C., Reynaud C.A. Proteasomal degradation restricts the nuclear lifespan of AID. J. Exp. Med. 2008, 205:1357-1368.
5. Bachl J., Carlson C., Gray-Schopfer V., Dessing M., Olsson C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 2001, 166:5051-5057.
6. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M., Nussenzweig M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 2003, 12:501-508.
7. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., Schrum J.P., Manis J.P., Alt F.W. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 2005, 438:508-511.
8. Basu U., Meng F.L., Keim C., Grinstein V., Pefanis E., Eccleston J., Zhang T., Myers D., Wasserman C.R., Wesemann D.R., Januszyk K., Gregory R.I., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011, 144:353-363.
9. Bentley D.L., Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 1986, 321:702-706.
10. Besmer E., Market E., Papavasiliou F.N. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol. Cell. Biol. 2006, 26:4378-4385.
11. Betz A.G., Milstein C., Gonzalez-Fernandez A., Pannell R., Larson T., Neuberger M.S. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: Critical role for the intron enhancer/matrix attachment region. Cell 1994, 77:239-248.
12. Both G.W., Taylor L., Pollard J.W., Steele E.J. Distribution of mutations around rearranged heavy-chain antibody variable-region genes. Mol. Cell. Biol. 1990, 10:5187-5196.
13. Bransteitter R., Pham P., Scharff M.D., Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 2003, 100:4102-4107.
14. Brar S.S., Watson M., Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 2004, 279:26395-26401.
15. Chatterji M., Unniraman S., McBride K.M., Schatz D.G. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation. J. Immunol. 2007, 179:5274-5280.
16. Chaudhuri J., Alt F.W. Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 2004, 4:541-552.
17. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 2003, 422:726-730.
18. Chiarle R., Zhang Y., Frock R.L., Lewis S.M., Molinie B., Ho Y.J., Myers D.R., Choi V.W., Compagno M., Malkin D.J., Neuberg D., Monti S., et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011, 147:107-119.
19. Cramer P., Armache K.J., Baumli S., Benkert S., Brueckner F., Buchen C., Damsma G.E., Dengl S., Geiger S.R., Jasiak A.J., Jawhari A., Jennebach S., et al. Structure of eukaryotic RNA polymerases. Annu. Rev. Biophys. 2008, 37:337-352.
20. Crouch E.E., Li Z., Takizawa M., Fichtner-Feigl S., Gourzi P., Montano C., Feigenbaum L., Wilson P., Janz S., Papavasiliou F.N., Casellas R. Regulation of AID expression in the immune response. J. Exp. Med. 2007, 204:1145-1156.
21. de Yebenes V.G., Belver L., Pisano D.G., Gonzalez S., Villasante A., Croce C., He L., Ramiro A.R. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 2008, 205:2199-2206.
22. Dedeoglu F., Horwitz B., Chaudhuri J., Alt F.W., Geha R.S. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int. Immunol. 2004, 16:395-404.
23. Delker R.K., Fugmann S.D., Papavasiliou F.N. A coming-of-age story: Activation-induced cytidine deaminase turns 10. Nat. Immunol. 2009, 10:1147-1153.
24. Di Noia J., Neuberger M. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 2007, 76:1-22.
25. Dickerson S.K., Market E., Besmer E., Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 2003, 197:1291-1296.
26. Doi T., Kato L., Ito S., Shinkura R., Wei M., Nagaoka H., Wang J., Honjo T. The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. USA 2009, 106:2758-2763.
27. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., San-Martin B.R., Heidkamp G., Schwickert T.A., Eisenreich T., Rajewsky K., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28:630-638.
28. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination: Complexes, ends, and transposition. Annu. Rev. Immunol. 2000, 18:495-527.
29. Gazumyan A., Timachova K., Yuen G., Siden E., Di Virgilio M., Woo E.M., Chait B.T., Reina San-Martin B., Nussenzweig M.C., McBride K.M. Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol. Cell. Biol. 2011, 31:442-449.
30. Geisberger R., Rada C., Neuberger M.S. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc. Natl. Acad. Sci. USA 2009, 106:6736-6741.
31. Gilmour D.S. Promoter proximal pausing on genes in metazoans. Chromosoma 2009, 118:1-10.
32. Gonda H., Sugai M., Nambu Y., Katakai T., Agata Y., Mori K.J., Yokota Y., Shimizu A. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 2003, 198:1427-1437.
33. Gordon M.S., Kanegai C.M., Doerr J.R., Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc. Natl. Acad. Sci. USA 2003, 100:4126-4131.
34. Gostissa M., Yan C.T., Bianco J.M., Cogne M., Pinaud E., Alt F.W. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region. Nature 2009, 462:803-807.
35. Guikema J.E., Schrader C.E., Leus N.G., Ucher A., Linehan E.K., Werling U., Edelmann W., Stavnezer J. Reassessment of the role of Mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching. J. Immunol. 2008, 181:8450-8459.
36. Houseley J., LaCava J., Tollervey D. RNA-quality control by the exosome. Nat. Rev. Mol. Cell Biol. 2006, 7:529-539.
37. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., Honjo T. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 2004, 101:1975-1980.
38. Jeevan-Raj B.P., Robert I., Heyer V., Page A., Wang J.H., Cammas F., Alt F.W., Losson R., Reina-San-Martin B. Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. J. Exp. Med. 2011, 208:1649-1660.
39. Jung D., Giallourakis C., Mostoslavsky R., Alt F.W. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 2006, 24:541-570.
40. Kim J.B., Sharp P.A. Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 2001, 276:12317-12323.
41. Klein B.J., Bose D., Baker K.J., Yusoff Z.M., Zhang X., Murakami K.S. RNA polymerase and transcription elongation factor Spt4/5 complex structure. Proc. Natl. Acad. Sci. USA 2011, 108:546-550.
42. Klein I.A., Resch W., Jankovic M., Oliveira T., Yamane A., Nakahashi H., Di Virgilio M., Bothmer A., Nussenzweig A., Robbiani D.F., Casellas R., Nussenzweig M.C. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011, 147:95-106.
43. Krokan H.E., Drablos F., Slupphaug G. Uracil in DNA-occurrence, consequences and repair. Oncogene 2002, 21:8935-8948.
44. Kracker S., Imai K., Gardes P., Ochs H.D., Fischer A., Durandy A.H. Impaired induction of DNA lesions during immunoglobulin class-switch recombination in humans influences end-joining repair. Proc. Natl. Acad. Sci. USA 2010, 107:22225-22230.
45. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 2005, 5:251-262.
46. Lebecque S.G., Gearhart P.J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 1990, 172:1717-1727.
47. Lis J.T. Imaging Drosophila gene activation and polymerase pausing in vivo. Nature 2007, 450:198-202.
48. Liu M., Schatz D.G. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 2009, 30:173-181.
49. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
50. Lumsden J.M., McCarty T., Petiniot L.K., Shen R., Barlow C., Wynn T.A., Morse H.C., Gearhart P.J., Wynshaw-Boris A., Max E.E., Hodes R.J. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 2004, 200:1111-1121.
51. Martinez-Rucobo F.W., Sainsbury S., Cheung A.C., Cramer P. Architecture of the RNA polymerase-Spt4/5 complex and basis of universal transcription processivity. EMBO J. 2011, 30:1302-1310.
52. Maul R.W., Gearhart P.J. AID and somatic hypermutation. Adv. Immunol. 2010, 105:159-191.
53. Maul R.W., Saribasak H., Martomo S.A., McClure R.L., Yang W., Vaisman A., Gramlich H.S., Schatz D.G., Woodgate R., Wilson D.M., Gearhart P.J. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat. Immunol. 2011, 12:70-76.
54. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P., Nussenzweig M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 2004, 199:1235-1244.
55. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 2006, 103:8798-8803.
56. McBride K.M., Gazumyan A., Woo E.M., Schwickert T.A., Chait B.T., Nussenzweig M.C. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 2008, 205:2585-2594.
57. McKean D., Huppi K., Bell M., Staudt L., Gerhard W., Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 1984, 81:3180-3184.
58. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
59. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
60. Muschen M., Re D., Jungnickel B., Diehl V., Rajewsky K., Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 2000, 192:1833-1840.
61. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 2003, 302:2137-2140.
62. Nowak U., Matthews A.J., Zheng S., Chaudhuri J. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat. Immunol. 2011, 12:160-166.
63. Nussenzweig A., Nussenzweig M.C. Origin of chromosomal translocations in lymphoid cancer. Cell 2010, 141:27-38.
64. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., Honjo T. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 2003, 197:1173-1181.
65. Okazaki I.M., Okawa K., Kobayashi M., Yoshikawa K., Kawamoto S., Nagaoka H., Shinkura R., Kitawaki Y., Taniguchi H., Natsume T., Iemura S., Honjo T. Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation. Proc. Natl. Acad. Sci. USA 2011, 108:7920-7925.
66. Oliveira T., Resch W., Jankovic M., Casellas R., Nussenzweig M.C., Klein I.A. Translocation capture sequencing: A method for high throughput mapping of chromosomal rearrangements. J. Immunol. Methods 2011.
67. Orthwein A., Patenaude A.M., Affar el B., Lamarre A., Young J.C., Di Noia J.M. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. J. Exp. Med. 2010, 207:2751-2765.
68. Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R.S., Klein U., Kuppers R., Rajewsky K., Dalla-Favera R. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 1998, 95:11816-11821.
69. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001, 412:341-346.
70. Pasqualucci L., Kitaura Y., Gu H., Dalla-Favera R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 2006, 103:395-400.
71. Patenaude A.M., Orthwein A., Hu Y., Campo V.A., Kavli B., Buschiazzo A., Di Noia J.M. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat. Struct. Mol. Biol. 2009, 16:517-527.
72. Pavri R., Gazumyan A., Jankovic M., Di Virgilio M., Klein I., Ansarah-Sobrinho C., Resch W., Yamane A., San-Martin B.R., Barreto V., Nieland T.J., Root D.E., et al. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 2010, 143:122-133.
73. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., Roa S., Kalis S.L., Goodman M.F., Scharff M.D. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 2008, 26:481-511.
74. Peters A., Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 1996, 4:57-65.
75. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
76. Pham P., Bransteitter R., Petruska J., Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 2003, 424:103-107.
77. Pham P., Smolka M.B., Calabrese P., Landolph A., Zhang K., Zhou H., Goodman M.F. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase. J. Biol. Chem. 2008, 283:17428-17439.
78. Potter M. Neoplastic development in plasma cells. Immunol. Rev. 2003, 194:177-195.
79. Rada C., Jarvis J.M., Milstein C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 2002, 99:7003-7008.
80. Rahl P.B., Lin C.Y., Seila A.C., Flynn R.A., McCuine S., Burge C.B., Sharp P.A., Young R.A. c-Myc regulates transcriptional pause release. Cell 2010, 141:432-445.
81. Rajagopal D., Maul R.W., Ghosh A., Chakraborty T., Khamlichi A.A., Sen R., Gearhart P.J. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J. Exp. Med. 2009, 206:1237-1244.
82. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
83. Ramiro A.R., Stavropoulos P., Jankovic M., Nussenzweig M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 2003, 4:452-456.
84. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004, 118:431-438.
85. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A., Nussenzweig M.C. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 2006, 440:105-109.
86. Ranjit S., Khair L., Linehan E.K., Ucher A.J., Chakrabarti M., Schrader C.E., Stavnezer J. AID binds cooperatively with UNG and Msh2-Msh6 to Ig switch regions dependent upon the AID C terminus. J. Immunol. 2011, 187:2464-2475.
87. Raschke E.E., Albert T., Eick D. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II. J. Immunol. 1999, 163:4375-4382.
88. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
89. Robbiani D.F., Bothmer A., Callen E., Reina-San-Martin B., Dorsett Y., Difilippantonio S., Bolland D.J., Chen H.T., Corcoran A.E., Nussenzweig A., Nussenzweig M.C. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008, 135:1028-1038.
90. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., McBride K.M., Klein I.A., Stone G., Eisenreich T.R., Ried T., Nussenzweig A., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
91. Rothenfluh H.S., Taylor L., Bothwell A.L., Both G.W., Steele E.J. Somatic hypermutation in 5' flanking regions of heavy chain antibody variable regions. Eur. J. Immunol. 1993, 23:2152-2159.
92. Rucci F., Cattaneo L., Marrella V., Sacco M.G., Sobacchi C., Lucchini F., Nicola S., Della Bella S., Villa M.L., Imberti L., Gentili F., Montagna C., et al. Tissue-specific sensitivity to AID expression in transgenic mouse models. Gene 2006, 377:150-158.
93. Sayegh C.E., Quong M.W., Agata Y., Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 2003, 4:586-593.
94. Sernandez I.V., de Yebenes V.G., Dorsett Y., Ramiro A.R. Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo. PLoS One 2008, 3:e3927.
95. Shen H.M., Peters A., Baron B., Zhu X., Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998, 280:1750-1752.
96. Shinkura R., Ito S., Begum N.A., Nagaoka H., Muramatsu M., Kinoshita K., Sakakibara Y., Hijikata H., Honjo T. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 2004, 5:707-712.
97. Sohail A., Klapacz J., Samaranayake M., Ullah A., Bhagwat A.S. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 2003, 31:2990-2994.
98. Staszewski O., Baker R.E., Ucher A.J., Martier R., Stavnezer J., Guikema J.E. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells. Mol. Cell. 2011, 41:232-242.
99. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
100. Steele E.J., Rothenfluh H.S., Both G.W. Defining the nucleic acid substrate for somatic hypermutation. Immunol. Cell Biol. 1992, 70(Pt 2):129-144.
101. Swanson M.S., Malone E.A., Winston F. SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol. Cell. Biol. 1991, 11:4286.
102. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 2003, 4:843-848.
103. Takizawa M., Tolarova H., Li Z., Dubois W., Lim S., Callen E., Franco S., Mosaico M., Feigenbaum L., Alt F.W., Nussenzweig A., Potter M., et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 2008, 205:1949-1957.
104. Teng G., Papavasiliou F.N. Immunoglobulin somatic hypermutation. Annu. Rev. Genet. 2007, 41:107-120.
105. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28:621-629.
106. Tran T.H., Nakata M., Suzuki K., Begum N.A., Shinkura R., Fagarasan S., Honjo T., Nagaoka H. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol. 2010, 11:148-154.
107. Tsai A.G., Lieber M.R. Mechanisms of chromosomal rearrangement in the human genome. BMC Genomics 2010, 11(Suppl. 1):S1.
108. Tumas-Brundage K., Manser T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J. Exp. Med. 1997, 185:239-250.
109. Vuong B.Q., Lee M., Kabir S., Irimia C., Macchiarulo S., McKnight G.S., Chaudhuri J. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat. Immunol. 2009, 10:420-426.
110. Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., Sugimoto S., Yano K., Hartzog G.A., Winston F., Buratowski S., Handa H. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 1998, 12:343-356.
111. Wang C.L., Harper R.A., Wabl M. Genome-wide somatic hypermutation. Proc. Natl. Acad. Sci. USA 2004, 101:7352-7356.
112. Wang L., Wuerffel R., Feldman S., Khamlichi A.A., Kenter A.L. S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination. J. Exp. Med. 2009, 206:1817-1830.
113. Weber J.S., Berry J., Manser T., Claflin J.L. Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus. J. Immunol. 1991, 146:3652-3655.
114. Weigert M.G., Cesari I.M., Yonkovich S.J., Cohn M. Variability in the lambda light chain sequences of mouse antibody. Nature 1970, 228:1045-1047.
115. Xu Z., Fulop Z., Wu G., Pone E.J., Zhang J., Mai T., Thomas L.M., Al-Qahtani A., White C.A., Park S.R., Steinacker P., Li Z., et al. 14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination. Nat. Struct. Mol. Biol. 2010, 17:1124-1135.
116. Yamada T., Yamaguchi Y., Inukai N., Okamoto S., Mura T., Handa H. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol. Cell 2006, 21:227-237.
117. Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., Hasegawa J., Handa H. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 1999, 97:41-51.
118. Yamane A., Resch W., Kuo N., Kuchen S., Li Z., Sun H.W., Robbiani D.F., McBride K., Nussenzweig M.C., Casellas R. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 2011, 12:62-69.
119. Yu K., Chedin F., Hsieh C.L., Wilson T.E., Lieber M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 2003, 4:442-451.
120. Zhang Y., Gostissa M., Hildebrand D.G., Becker M.S., Boboila C., Chiarle R., Lewis S., Alt F.W. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Adv. Immunol. 2010, 106:93-133.
121. Zhou C., Saxon A., Zhang K. Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: Implication of CD45 as a Janus kinase phosphatase in antibody diversification. J. Immunol. 2003, 170:1887-1893.